Parallax Volatility Advisers’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-35,994
| Closed | -$740K | – | 907 |
|
|
2024
Q3 | $740K | Buy |
+35,994
| New | +$740K | ﹤0.01% | 365 |
|
|
2023
Q2 | – | Sell |
-25,005
| Closed | -$932K | – | 1063 |
|
|
2023
Q1 | $932K | Hold |
25,005
| – | – | ﹤0.01% | 313 |
|
|
2022
Q4 | $872K | Buy |
25,005
+21,108
| +542% | +$736K | ﹤0.01% | 355 |
|
|
2022
Q3 | $218K | Sell |
3,897
-26,239
| -87% | -$1.47M | ﹤0.01% | 612 |
|
|
2022
Q2 | $1.56M | Buy |
+30,136
| New | +$1.56M | ﹤0.01% | 322 |
|
|
2021
Q4 | – | Sell |
-22
| Closed | -$3K | – | 861 |
|
|
2021
Q3 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 642 |
|
|
2020
Q4 | – | Sell |
-8,900
| Closed | -$177K | – | 1212 |
|
|
2020
Q3 | $177K | Buy |
+8,900
| New | +$177K | ﹤0.01% | 916 |
|
|
2018
Q3 | – | Sell |
-10,595
| Closed | -$290K | – | 2020 |
|
|
2018
Q2 | $290K | Buy |
+10,595
| New | +$290K | ﹤0.01% | 383 |
|
|
2018
Q1 | – | Sell |
-2,142
| Closed | -$41K | – | 2454 |
|
|
2017
Q4 | $41K | Buy |
+2,142
| New | +$41K | ﹤0.01% | 2196 |
|